New York, New York, United StatesFounded 2018194+ employeesPrivate
$295M raisedGrowth· last: series b (Oct 2021)· 3 rounds
Backed by(14 investors)
Koch Disruptive Technologies · LeadCharles and Lynn Schusterman Family Philanthropies · LeadDuquesne Family Office · LeadViola Group · LeadCatalio Capital Management · LeadDexcel Pharma · LeadTLV Partners · Lead+6 more
Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
